Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors
Status:
Completed
Trial end date:
2003-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase I/II trial to study the effectiveness of irofulven in treating patients who
have progressive or recurrent astrocytoma, oligodendroglioma, or glioblastoma multiforme.